Status:
UNKNOWN
NEMO - an App for Side Effect Management in Oncology
Lead Sponsor:
Thomas Seufferlein
Conditions:
Cancer Patients
Eligibility:
All Genders
18+ years
Brief Summary
This study investigates the use of digital and standardized documentation by patients of frequently occurring adverse events in oncological therapies.
Detailed Description
This research study is structured as a Phase I and II clinical trial. In phase I, the feasibility of using a smartphone application to document adverse events that have occurred during oncological the...
Eligibility Criteria
Inclusion
- infusional combination therapy with at least two chemotherapy substances with or without further targeted therapies
- combination of at least two immune-checkpoint inhibitors
- able to read and understand German
Exclusion
- Participants who meet any of the following criteria will be excluded:
- severe neurological disorders
- severe psychiatric disorders
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04493450
Start Date
September 1 2020
End Date
June 30 2022
Last Update
August 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Ulm
Ulm, Germany